Efficacy of Olanzapine 5 mg versus 10 mg for the Prophylaxis of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving High Emetic Risk Chemotherapy without Neurokinin-1 Receptor Antagonist

OBJECTIVE: To compare the efficacy and safety of two different dosage levels of olanzapine for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high emetic risk chemotherapy. METHODS: This study was a randomized, double-blind, controlled trial designed to show...

Descripción completa

Detalles Bibliográficos
Autores principales: Sukauichai, Sitthi, Ketkaew, Chaninun, Othaganont, Naparat, Pichaya, Pichayapa, Promsuwan, Pimonwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587814/
https://www.ncbi.nlm.nih.gov/pubmed/35763658
http://dx.doi.org/10.31557/APJCP.2022.23.6.2137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587814/
https://www.ncbi.nlm.nih.gov/pubmed/35763658
http://dx.doi.org/10.31557/APJCP.2022.23.6.2137

Ejemplares similares